Titan Securities Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The company's Board of Directors approved both standalone and consolidated financial statements in a meeting held on November 11, 2025.

Key Highlights

• The board meeting commenced at 17:00 PM and concluded at 17:30 PM on November 11, 2025.
• The financial results have been reviewed by statutory auditors and are available on the company's website.
• Consolidated results include Titan Biotech Limited and Peptech Biosciences Limited as associates.

Financial Performance

The consolidated results of Titan Securities Limited showcase the company's performance including its associate companies. For the quarter ended September 30, 2025:

These figures represent the contribution from Titan Securities Limited's associate companies, Titan Biotech Limited and Peptech Biosciences Limited.

Auditor's Review

A N S K & Associates, Chartered Accountants, conducted an independent review of both standalone and consolidated financial results. Key points from their review include:

• The financial statements comply with Indian Accounting Standard 34 (Ind AS 34) and other accounting principles generally accepted in India.
• The auditors found no material misstatements in the financial disclosures.
• The review was conducted in accordance with the Standard on Review Engagements (SRE) 2410.

Corporate Governance

Titan Securities Limited has adhered to the regulatory requirements by:

• Submitting the financial results in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• Providing Limited Review Reports for both standalone and consolidated financial statements.
• Ensuring transparency by making the financial results available on the company's official website.

The company's commitment to timely disclosure and regulatory compliance underscores its focus on maintaining good corporate governance practices.

Investors and stakeholders can access detailed financial statements and auditor's reports on the company's website for a comprehensive understanding of Titan Securities Limited's financial position and performance for the quarter ended September 30, 2025.

Titan Securities Limited has announced the re-appointment of Mrs. Manju Singla as Managing Director for a five-year term, subject to shareholder approval at the upcoming 33rd Annual General Meeting (AGM). The Board of Directors approved this decision in their meeting held on August 25, 2025.

Key Points of the Re-appointment

• Term: Mrs. Singla's new term as Managing Director will commence on October 1, 2025, for a period of five years.
• Remuneration: The re-appointment is being made without any remuneration.
• Shareholder Approval: The decision is subject to approval at the 33rd AGM scheduled for September 26, 2025.
• Position: Mrs. Singla will not be liable to retire by rotation in her role as Managing Director.

About Manju Singla

Mrs. Manju Singla has been an integral part of Titan Securities Limited since November 25, 2002. During her tenure, she has played a significant role in:

• Driving strategic initiatives
• Maintaining high corporate governance standards
• Improving operational efficiency
• Enhancing stakeholder engagement

Her strong domain expertise in capital markets has been a valuable asset to the company.

Additional Details

• Shareholding: Mrs. Singla holds 34,43,128 equity shares in the company.
• Relationship: She is the spouse of Mr. Suresh Chand Singla (DIN: 00027706), who serves as a Director of the company.

Upcoming Annual General Meeting

The 33rd AGM of Titan Securities Limited is scheduled as follows:

The company will send the Annual Report for the financial year 2024-25, including the AGM Notice, to all members via electronic mode. It will also be available on the company's website at www.titansecuritieslimited.com .

Titan Securities Limited has assured that Mrs. Manju Singla is not debarred from holding a directorship by any SEBI circular/order or other authority. The re-appointment aligns with the company's commitment to maintaining strong leadership and corporate governance standards.